Article
TP53-binding protein variants and breast cancer risk: a case-control study.
Breast cancer research : BCR - 1 Jan 2005
Frank Bernd, Hemminki Kari, Bermejo Justo Lorenzo, Klaes Rüdiger, Bugert Peter, Wappenschmidt Barbara, Schmutzler Rita K, Burwinkel Barbara
Abstract excerpt
INTRODUCTION: The TP53-binding protein (53BP1) has been shown to influence TP53-mediated transcriptional activation, thus playing a pivotal role in DNA damage signalling. Genetic aberrations in TP53 and in ATM and CHEK2 predispose to cancer. We have therefore examined the effects of 53BP1 single nucleotide polymorphisms (D353E, G412S, and K1136Q) and the novel 53BP1 6bp deletion (1347_1352delTATCCC) on breast...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
